At Hovione Capital, we work closely with our entrepreneurs to build leading companies with technologies and products designed to positively impact people’s health.

We help companies to bridge research and development through our team’s expertise in drug development and company building.

We invest in early-stage life sciences companies, with a particular focus on Therapeutics, MedTech and Digital Health, mainly in Europe.

We typically invest between €200,000 to €1,000,000 per project, usually bringing additional healthcare-specialized investors to the Company to add value and mitigate risk.

Projects must meet several critical points before we are able to invest, please see our Investment Criteria page before sending us an investment proposal.

Your cookie settings

We ask you to accept cookies for the purpose of performance, social networking and advertising.
For more information or correct your preferences, press the button "more info".
For more information about these cookies and the processing of your personal data, check out our cookie and Privacy Policy. Accept these cookies and the processing of personal data involved?

Accept cookies More information